sorry, but this article clearly shows that big cat does not at all understand the mechanisms by which tamoxifen and clomiphene work. It has nothing to do with potency and everything to due with ER subtype affinity and action, as well as tissue affinity.
tamoxifen does NOT stimulate LH release. Its action, an ESTROGENIC ACTION BTW, on the HPG axis is to prime GnRh, if you are suppressed and not releasing significant LH, this is pretty much worthless. Clomiphene directly stimulates LH release, an ER ANTAGONIST action in the hypothalamus. Also contrary to popular belief, tamoxifen actually suppresses LH via estrogenic action-- AGAIN.
this is what happens when a northerner reads and fails to actually check the research by bill lewellyn's theories. Though believe that even bill and perhaps andy have even stepped away from the nolva only PCT.
J Endocrinol Invest. 2006 Jun;29(6):485-96. Links
Mechanism delineating differential effect of an antiestrogen, tamoxifen, on the serum LH and FSH in adult male rats.Balasinor N, Parte P, Gill-Sharma MK, Kini J, Juneja HS.
Division of Neuroendocrinology, National Institute for Research in Reproductive Health, Parel, Mumbai 400012, India.
nafisabala@hotmail.com
Tamoxifen, a synthetic non-steroidal antiestrogen with residual estrogenic activity, administered to adult male rats reduces their fertility. A decrease in the circulating LH and testosterone levels with a transient rise or no change in circulating FSH levels was observed. The present study was carried out to delineate the mechanism causing the differential effect of tamoxifen on circulating gonadotropins by correlating it to changes in the hypothalamic LHRH, pituitary gonadotropins and testicular inhibin/activin. Hypothalamus, pituitary-hypothalamus complex (PHC) and intact pituitary (PI) from control and tamoxifen-treated male rats were superfused in vitro, and pulsatile release of LHRH by hypothalamus and that of LH and FSH by the PHC and PI were studied. Concomitantly, testicular immunoexpression of alpha and betaB subunits of inhibin/activin were studied by immunohistochemistry and enzyme-linked immunosorbent assays (ELISA). At 0.4 mg/kg/day dose of tamoxifen a decrease in mean hypothalamic LHRH and LH pulse frequency from PHC construct was observed. FSH pulse frequency was not affected under the same experimental conditions. At the same dose of tamoxifen, testicular expression of both alpha and betaB subunits of inhibin/activin was upregulated.
The study demonstrated that reduced circulating LH levels were due to a decrease in hypothalamic LHRH concentration and in LH pulsatility following tamoxifen treatment. The lack of effect on circulating FSH under the same experimental conditions was likely due to its modulation by inhibin and activin.
Tamoxifen-induced light and electron microscopic changes in the rat testicular morphology and serum hormonal profile of reproductive hormones.Gopalkrishnan K, Gill-Sharma MK, Balasinor N, Padwal V, D'Souza S, Parte P, Jayaraman S, Juneja HS.
Institute for Research in Reproduction, Bombay, India.
The effects of oral administration of tamoxifen at doses of 40 and 200 micrograms/kg/day on testicular histology, testicular ultrastructure and serum hormonal profile were studied. The drug was administered to adult male rats over a period of 90 days and the effect was assessed at 10-day intervals. The morphometry, microscopic structures of the testis, including ultrastructure and daily sperm production rate, were evaluated. The hormone profiles of luteinizing hormone (LH), follice-stimulating hormone (FSH), testosterone, and estradiol were studied. The testes from treated animals showed disorganization of tubular elements with increased intercellular space. At day 50, the changes were extensive including presence of phagosomes. Morphometric studies showed a reduction in the spermatid and spermatozoan population (69.3%) with no changes in tubular diameter. The mean Leydig cell area was significantly lowered at day 50, at both doses. The daily sperm production rate was reduced as compared with controls. An array of degenerative changes were revealed by ultrastructural studies. The changes were extensive at day 50 at both doses. The characteristic features were lost in most of the cells with phagolysosomes becoming abundant. The cytoplasm of the cells was dense with poorly defined cytoplasmic organelles. Circulating LH levels were not modified at the 40 micrograms/kg/day dose but at 200 micrograms/kg/day, LH levels were significantly decreased. Initial transitory rise in FSH was seen with both doses.
Both doses of tamoxifen decreased testosterone levels. Changes in the circulating estradiol levels were inconsistent, and no apparent relationship between dose and days of treatment was observed. Thus, this study supports our thesis of tamoxifen as a potential male contraceptive agent.
nolva after 1-t and perhaps even epistane , which is not and does not have the same activity as the studied epitiostanol, may be involved with the PgR and increases gyncomastia. Clomid and perhaps low dose AIFM or exemestane, supress E to much and you lose priming effect